Divi's Laboratories Limited (DIVISLAB) — Financial Results Announcement
📢 Key Event
Divi's Laboratories filed unaudited Q3 and nine-month financial results for period ended December 31, 2025.
💡 Investor Takeaway
No financial data available in this regulatory filing submission; investors must refer to the actual newspaper publications or company website for Q3 FY2026 results.
Divi's Laboratories Limited published unaudited financial results for Q3 and nine-month period ended December 31, 2025. The company filed newspaper clippings with NSE and BSE as per regulatory requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing was made on February 12, 2026 in Financial Express (English) and Andhra Prabha (Telugu).
📄 View Original Announcement (PDF)
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,79,470.03 Cr
P/E: 72.4
ROE: 16.6%
ROCE: 22.1%
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.